San Francisco is one of seven winners of a national competition to encourage mentoring in science, technology, engineering and mathematics (STEM), with an initiative to be led by UCSF.
Research led by a UCSF investigator establishes a new benchmark in the treatment of patients with metastatic colorectal cancer and sets a new expectation for how long patients can live with the particularly lethal disease.
From prostate cancer to immunotherapy to genetic testing, UCSF research is providing new insights and aiding in the development of new treatment strategies for cancer.